Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Potential trends in the molecular profiling of breast cancer

Sofia Mastoraki • 11 Apr 2022
AACR 2022
Breast Cancer

Sofia Mastoraki, PhD, University of Texas MD Anderson Cancer Center, Houston, TX discusses molecular profiling and the need for biomarkers which can predict responses to immunotherapy in patients with breast cancer. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2022 in New Orleans, LA.

More from Sofia Mastoraki

1:13
Advantages and disadvantages of next-generation sequencing techniques for tumor research
Sofia Mastoraki • 11 Apr 2022
1:39
Using single cell technologies to identify biomarkers for breast cancer patient outcomes
Sofia Mastoraki • 11 Apr 2022

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals